Introduction
============

Epidural anesthesia is a powerful method for relieving pain during labor. Continuous advancements have been made in the epidural technique for labor analgesia, with development of epidural infusion pumps including the high-pressure pump.^\[[@R1]\]^ With a fixed volume of anesthetic automatically pumped at scheduled intervals, the programmed intermittent epidural bolus (PIEB) technique has gradually replaced continuous epidural infusion (CEI) and is now extensively used in obstetric analgesia for superior maternal satisfaction and a lower incidence of adverse events.^\[[@R2]--[@R7]\]^

Regretfully, the parameter settings of PIEB have not been definitively standardized and the settings for an optimal PIEB regimen to improve the effect of labor analgesia remain unclear. Recently, some studies have suggested that the epidural catheter size and type and the flow rate have an effect on epidural analgesia.^\[[@R8],[@R9]\]^ However, other studies have focused more on the pump settings.^\[[@R1],[@R10],[@R11]\]^ For example, a dose-finding study was performed to establish the PIEB pump settings of bupivacaine 0.0625% with fentanyl 2 μg/mL.^\[[@R11]\]^ According to the parameter settings, PIEB can achieve an ideal and desired level of pain relief, without the use of supplementary measures, in 90% of parturients during the first stage of labor. The study suggested that the optimal interval duration for PIEB with bupivacaine and fentanyl was approximately 40 min.

Combined ropivacaine 0.08% and sufentanyl 0.3 μg/mL is a standard regimen to treat labor pain in China, and it is the most commonly used in our hospital. As an amide-type local anesthetic, ropivacaine has pharmacological properties similar to those of bupivacaine. Ropivacaine has increasingly replaced bupivacaine in obstetric anesthesia, because it causes less motor blockade and cardiovascular and central nervous system toxicity.^\[[@R12],[@R13]\]^ In terms of efficacy for labor analgesia, ropivacaine has been determined to be approximately 60% as potent as bupivacaine in a study.^\[[@R14]\]^ However, Wang *et al*^\[[@R15]\]^ found that the analgesic efficacy of bupivacaine and ropivacaine mainly depends on the concentration rather than the type of anesthetics. It could not be assumed that the optimal interval duration for PIEB with ropivacaine and sufentanyl was the same as that of PIEB with bupivacaine and fentanyl.

Thus, we here investigated the optimal interval duration for PIEB with ropivacaine 0.08% and 0.3 μg/mL sufentanyl to prevent breakthrough pain during the first stage labor in 90% of parturients.

Methods
=======

Ethical approval
----------------

This study was undertaken in a tertiary maternity hospital in China. The study was approved by the Ethics Committee of Fujian Provincial Maternity and Children Hospital (No.2019-021). This prospective, double-blind trial was conducted using a biased-coin up-and-down sequential allocation method, from April to May 2019. We obtained written consent from each parturient and their families.

Study design and population
---------------------------

We included the American Society of Anesthesiologists physical status classification II--III primiparous, singleton women in labor at more than 37 weeks of gestation, with cervical dilation of 2 to 5 cm, and a visual analog scale (VAS, 0--10 points, with VAS 0 = no pain and 10 = the worst imaginable pain) score exceeding 5, who requested epidural labor analgesia. We excluded parturients in case of major anomalies of the fetus, intrauterine growth retardation, fetal distress, or non-vertex presentation; maternal factors for exclusion included allergy or hypersensitivity to ropivacaine or sufentanyl, contraindications to epidural analgesia, significant bleeding during pregnancy, significant medical disease, such as cardiopulmonary dysfunction, severe pregnancy-induced hypertension, receipt of parenteral opioids in the previous 4 h, or a body mass index of greater than 35 kg/m^2^, and unintentional dural puncture.

For a biased-coin up-and-down design, at least 20 to 40 parturients must be enrolled to provide a stable estimate of the target dose in most cases, according to simulation studies.^\[[@R16],[@R17]\]^ Therefore, 44 parturients were enrolled in this study.

Anesthetic procedure
--------------------

After the eligible parturients arrived in the delivery room, standard monitoring procedures including recording of baseline maternal heart rate, non-invasive blood pressure, type of labor (spontaneous or induced), dosage of oxytocin used, and VAS score were performed. Venous access for intravenous (IV) fluids was established through which Ringer lactate was administered.

Epidural puncture was performed at the L2--3 vertebral interspace, using a loss of resistance technique, and the catheter was inserted into the epidural space with a depth of about 3 to 4 cm. The parturient was placed in the supine position with a left lateral tilt after the catheter was fixed. Then, 3 mL 1.73% lidocaine carbonate (Zhuhai Rundu Pharmaceutical Co., Ltd., China) was injected to rule out the possibility of subarachnoid injection or IV injection in the next 5 min.

Subsequently, a loading dose of 10 mL of ropivacaine (AstraZeneca AB, Sweden) 0.08% with sufentanyl (Yichang Renfu Pharmaceutical Co., Ltd., Hubei, China) 0.3 μg/mL was administered through the catheter. The VAS score was assessed in the following 20 and 60 min, and only parturient whose VAS score was less than 1 continued in the study. A solution of ropivacaine 0.08% with sufentanyl 0.3 μg/mL was administered as a bolus via the PIEB pump 1 h after administration of the loading dose.

The patient-controlled epidural analgesia (PCEA) settings were as follows: 10 mL initial bolus, 5 mL subsequent bolus dose, and 10-min lockout interval. The parturients were assigned to groups 60, 50, 40, and 30 according to the set interval duration. The study was performed using the biased-coin method, with biased-coin allocation based on an Excel-generated list of random responses prepared by the research investigator.^\[[@R1],[@R10],[@R11]\]^ The research investigator would enter the data and unveil the allocated interval for the parturient to a specific nurse. After receiving the information, the nurse would set up the epidural pump and cover the pump with an opaque bag. Neither the parturient nor the anesthetist was aware of the pump settings.

If the parturient felt pain during the labor, the parturient could press the PCEA device button or ask the anesthetist to take measures to relieve her pain. In that case, the analgesic regimen with the given interval duration was considered to be ineffective.

Assessments were conducted by an anesthetist every hour after the initiation of the PIEB until completion of the study. The completion of the study was defined as 6 h after the initiation of PIEB or the end of the first stage of labor, whichever occurred first. The severity of pain is known to become markedly more intense as labor progresses. During the second stage of labor, in particular, labor pain is complex and is influenced by many factors.^\[[@R18]\]^ Thus, to assess the effectiveness of this PIEB regimen, we included only observations of the 6 h in the first stage of labor.

We regarded effective analgesia as the primary outcome, we defined it as no use of requirement for additional measures to relieve labor pain, such as a PCEA or a manual bolus before completion of the study.

Secondary outcomes were as follows: the maximum sensory block level (detected by applying ice in the midclavicular line), motor block degree in the leg (assessed using the modified Bromage score), and non-invasive blood pressure (assessed between uterine contractions).^\[[@R19],[@R20]\]^

Statistical analysis
--------------------

The statistic part of our study is instructed by a professional statistician. Parturient characteristics and the secondary outcomes were summarized descriptively between various time interval groups. The primary outcome of effective interval (EI) 90% and its 95% confidence interval (CI) was estimated using the truncated Dixon and Mood method and the isotonic regression analysis method, with the pooled-adjacent-violators algorithm approach. These are two non-parametric methods which have been used and described previously in similar studies.^\[[@R11]\]^ Statistical analyses were performed using the SPSS software version 20.0 (SPSS, Inc., Chicago, IL, USA) and the R package (R version 3.1.3; [www.r-project.org](http://www.r-project.org/)).^\[[@R21]\]^

Results
=======

From April 2019 to May 2019, fifty-one parturients participated in the study. Three parturients were excluded from the analysis because they had a VAS score exceeding 1 within 20 min after administration of the loading dose. Two parturients were excluded because their conditions warranted cesarean deliveries. Two parturients were excluded because they suspended the use of the pump due to not feeling uterine contractions. Finally, forty-four parturients were included in the data analysis. Parturient demographics and labor characteristics are analyzed in Table [1](#T1){ref-type="table"}. The parturients allocation sequence and response to different PIEB interval times are shown in Figure [1](#F1){ref-type="fig"}.

###### 

Characteristics of parturients included in the study (*n* = 44).

![](cm9-133-517-g001)

![Patient allocation sequence and response to the assigned PIEB interval time. An effective PIEB interval time is expressed by a circle, while an ineffective one is expressed by a triangle. PIEB: Programmed intermittent epidural bolus.](cm9-133-517-g002){#F1}

Using the truncated Dixon and Mood method, the estimated effective interval 90% (EI90%) was 44.1 min (95% CI 41.7--46.5 min). Using the isotonic regression analysis, the estimated EI90% was 39.5 min (95% CI 32.5--50.0 min). Considering the two results, we regard approximately 42 min as the optimal interval time.

Effective analgesia of 100% and 89% were achieved in groups 30 and 40, respectively. The response rate for each interval time and the adjusted response rates are shown in Table [2](#T2){ref-type="table"}. We also summarize the time to PCEA requests after administrating the loading doses in parturients who did not respond to the protocol. Eight parturients failed to reach adequate analgesia with the proposed PIEB regimen. There were two parturients in group 60 who did not achieve adequate analgesia, and the time from PIEB to first bolus rescue was 204 and 98 min, respectively. There were four parturients in group 50 who failed to reach adequate analgesia, and the time from PIEB to first bolus rescue was 120, 197, 105, and 182 min, respectively. There were two parturients in group 40 that did not achieve adequate analgesia, and the time from PIEB to PCEA request was 345 and 240 min, respectively. All the parturients in group 30 achieve adequate analgesia. Parturients in group 30 presented with a higher sensory block level upon ice stimulation than other groups. Almost 20% of the parturients in group 30 presented with sensory blocks above T6, the rate was 5.3%, 0, and 0 in groups 40, 50, and 60, respectively. None of the parturients in group 30 presented with sensory block levels lower than T8. Moreover, no case of hypotension was observed in the study. There was only one parturient in group 30 who presented with motor block. The maximum sensory block level, degree of motor block, and any possible adverse events in each sub-group are shown in Table [3](#T3){ref-type="table"}.

###### 

Observed response rate of parturients with successful analgesia and PAVA-adjusted response rate.
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###### 

Degree of motor block, sensory block levels, and adverse events.
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Discussion
==========

In this study, we obtained the EI90% for PIEB with 10 mL of ropivacaine 0.08% and sufentanyl 0.3 μg/mL in nulliparous parturients during the first stage of labor. Our study showed that the optimal interval time is approximately 42 min. The corresponding hourly consumption of ropivacaine was 12 mg, which was found to be safe for epidural analgesia.

Although ropivacaine has similar pharmacological properties to bupivacaine, it induces less motor blockade and thus lower rates of instrumental vaginal delivery. It has, therefore, largely replaced bupivacaine during labor. Ropivacaine is a long-acting local anesthetic, nevertheless, it has been shown in some studies that ropivacaine is less potent than bupivacaine.^\[[@R14]\]^ We used the same bolus volumes and duration of time intervals as in a study by Epsztein *et al*^\[[@R11]\]^ where bupivacaine 0.0625% with fentanyl 2 μg/mL was used as the analgesic regimen rather than ropivacaine 0.08% with sufentanil 0.3 μg/mL. In the study, we observed that the incidence of motor blockade was significantly lower than that of the study.^\[[@R1],[@R11]\]^ Only one parturient developed motor blockade, which was assessed as Bromage score 1.

Our study demonstrated that shorter PIEB intervals of 30 to 40 min may induce higher sensory block levels than longer PIEB intervals (50--60 min). In our study, more than 5.3% and 20% of the parturients developed a sensory block above T6 in groups 40 and 30, respectively. Nevertheless, the maximum sensory block level of ropivacaine was found to be lower than that of bupivacaine. Aside from the lower incidence of motor blockade, no cases of hypotension were reported for ropivacaine. While two parturients complained of pruritus, no other occurrences of adverse effects or discomfort in the parturients were observed. PIEB with ropivacaine and sufentanyl was found to be much safer than that of bupivacaine and fentanyl.

We did not use the degree of satisfaction in parturients as an outcome variable in our study. In fact, we assessed the patient satisfaction score in our study. The parturients were instructed to press the PCEA button or requested a physician-delivered top-up if contractions were uncomfortable, so all the parturients were satisfied with labor analgesia.

The analgesia rate during labor in China is still tentatively less than 10% even in more developed areas such as Beijing. The Chinese government is attempting to popularize labor analgesia and increase the labor analgesia rate.^\[[@R22]\]^ However, there is a critical shortage of anesthetists in many hospitals, we thus carried out this study to standardize analgesic protocol for improving safety and efficacy during labor.

Our study had some limitations. First, we only investigated nulliparous women during the first stage of labor with cervical dilation less than 5 cm. Consequently, our results could not apply to more advanced labor stages or multiparous women. Secondly, epidural analgesia administration is not uniform. The anesthetists can choose different types and doses of local anesthetic agents and adjuvant drugs, and different techniques to maintain epidural analgesia for the duration of labor. Evidence suggests that altering these variables may influence the outcomes of labor analgesia. Thus, our results only applied to PIEB with ropivacaine 0.08% and 0.3 μg/mL sufentanyl.

In conclusion, the EI90% for PIEB with 10 mL of ropivacaine 0.08% and sufentanyl 0.3 μg/mL is approximately 42 min. With the recommended PIEB interval time, the parturient can avoid breakthrough pain and make fewer additional requests for PCEA or manual bolus, which will allow the anesthetists to more effectively provide comfort to a greater number of parturients undergoing labor. However, future larger studies are warranted to confirm other PIEB settings and to address the analgesic needs of parturients in all stages of labor.
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